Metabolic Impact of Frailty Changes Diabetes Trajectory
Metabolites · 16.02.2023 · 13 (2) · 295
DOI: 10.3390/metabo13020295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 16.02.2023. Verfasst von Alan J Sinclair und 1 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Diabetes Research in Older People (fDROP), King's College, London WC2R 2LS, UK. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus, Gerontologische Pflege
Abstract (Originalsprache)
Diabetes mellitus prevalence increases with increasing age. In older people with diabetes, frailty is a newly emerging and significant complication. Frailty induces body composition changes that influence the metabolic state and affect diabetes trajectory. Frailty appears to have a wide metabolic spectrum, which can present with an anorexic malnourished phenotype and a sarcopenic obese phenotype. The sarcopenic obese phenotype individuals have significant loss of muscle mass and increased visceral fat. This phenotype is characterised by increased insulin resistance and a synergistic increase in the cardiovascular risk more than that induced by obesity or sarcopenia alone. Therefore, in this phenotype, the trajectory of diabetes is accelerated, which needs further intensification of hypoglycaemic therapy and a focus on cardiovascular risk reduction. Anorexic malnourished individuals have significant weight loss and reduced insulin resistance. In this phenotype, the trajectory of diabetes is decelerated, which needs deintensification of hypoglycaemic therapy and a focus on symptom control and quality of life. In the sarcopenic obese phenotype, the early use of sodium-glucose transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists is reasonable due to their weight loss and cardio–renal protection properties. In the malnourished anorexic phenotype, the early use of long-acting insulin analogues is reasonable due to their weight gain and anabolic properties, regimen simplicity and the convenience of once-daily administration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Foundation for Diabetes Research in Older People (fDROP), King's College, London WC2R 2LS, UK.
- Department of Geriatric Medicine Rotherham General Hospital, Rotherham S60 2UD, UK.
Zitieren
APA
Sinclair, A. J., & Abdelhafiz, A. H. (2023). Metabolic Impact of Frailty Changes Diabetes Trajectory. Metabolites, 13(2), 295. https://doi.org/10.3390/metabo13020295
Vancouver
Sinclair AJ, Abdelhafiz AH. Metabolic Impact of Frailty Changes Diabetes Trajectory. Metabolites. 2023;13(2):295. doi:10.3390/metabo13020295
BibTeX
@article{Sinclair2023,
author = {Sinclair, Alan J and Abdelhafiz, Ahmed H},
title = {Metabolic Impact of Frailty Changes Diabetes Trajectory},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {2},
pages = {295},
doi = {10.3390/metabo13020295}
}
EUVIMED